Homeopathic treatment of nicotine dependence

Phase 2

• Conditions: Health Condition 1: null- Nicotine dependence

• Registration Number: CTRI/2018/04/013329
• Lead Sponsor: ational Institute of Homoeopathy Ministry of AYUSH Govt of India

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Age 18-65 years

2. Both sexes

3. Participants suffering from Nicotine dependence; i.e. currently using the substance (ICD-10 F17.24) and continuous use (ICD-10 F17.25)

4. Literate patients; ability to read English and/or Bengali

5. Patients willing to participate in the study and giving written informed consent

Exclusion Criteria

1. Patients having mental and behaviour disorder due to psychoactive substance other than tobacco

2. Currently and continuous users of smokeless tobacco

3. Other forms of substance abuse and/or dependence

4. Patient suffering from mental and behaviour disorder due to tobacco, acute intoxication F17.0, Harmful uses F17.1, withdrawal state F17.3, withdrawal state with delirium F17.4, Psychotic disorder F17.5, Amnesic Syndrome F17.6, Residual & late onset psychotic disorder F17.7.

5. Patient suffering from Nicotine dependence who are currently abstinent F17.20, Currently abstinent but in a protracted environment F17.21, Currently on a clinically supervised maintenance or replacement regime [controlled dependence] F17.22, Currently abstinent but receiving treatment with aversive or blocking drugs F17.23, Episodic use F17.26.

6. Self-reported immune-compromised state

7. Patient is already undergoing nicotine replacement therapy

8. Patient already undergoing homoeopathic treatment elsewhere for any chronic disease

9. Any symptoms suggestive of any serious medical conditions that may require active intervention within 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fagerström Test for Nicotine Dependence (FTND); translated Bengali versionTimepoint: At baseline, every 6 weeks, up to 6 months

Secondary Outcome Measures

Name	Time	Method
oneTimepoint: NA